Price Marianne O, Knight OʼRese J, Benetz Beth Ann, Debanne Sara M, Verdier David D, Rosenwasser George O, Rosenwasser Miriam, Price Francis W, Lass Jonathan H
*Cornea Research Foundation of America, Indianapolis, IN; †Case Western Reserve University Department of Ophthalmology and Visual Sciences and University Hospitals Eye Institute, Cleveland, OH; ‡Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH; §Verdier Eye Center, Grand Rapids, MI; ¶Central Pennsylvania Eye Institute, Hershey, PA; and ‖Price Vision Group, Indianapolis, IN.
Cornea. 2015 Mar;34(3):253-6. doi: 10.1097/ICO.0000000000000354.
The aim of this study was to compare endothelial cell loss and graft success 6 months after endothelial keratoplasty (EK) with paired donor corneas stored in Optisol GS and Life4°C solutions and their associated storage chambers.
Donor pairs were stored, one in Optisol GS and the other in Life4°C, and prepared for Descemet stripping automated EK or Descemet membrane EK. Matched pairs of recipients with Fuchs dystrophy were randomized to 1 member of each donor pair. Clarity of recipient stroma, intraocular pressure, and complications were followed for 6 months. Central endothelial images of the donor cornea at screening and 3 and 6 months after EK were analyzed by a masked central reading center. Dual grading of endothelial cell density was performed using the center method. Differences in endothelial cell density and cell loss were examined by paired analysis.
Thirty-two pairs were enrolled, and 27 were analyzed (5 had improper matching or loss to follow-up). Donor age was 59 ± 14 years, median death-to-surgery time was 4 days (range, 2-9 days), 6 recipient pairs had Descemet membrane EK, and 21 had Descemet stripping automated EK. Recipient age was comparable in the Optisol GS and Life4°C groups (70 vs. 68 years, respectively, P = 0.46). Six-month central endothelial cell loss did not differ significantly between the Life4°C and Optisol GS groups (18 ± 18% vs. 20 ± 20%, respectively, P = 0.55). All recipient corneas were clear at 6 months in both groups.
Endothelial cell loss and graft success were comparable at 6 months for paired donor corneas stored in Optisol GS and Life4°C.Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01657500.
本研究旨在比较使用Optisol GS溶液和Life4°C溶液及其相关储存盒储存的配对供体角膜在内皮角膜移植术(EK)6个月后的内皮细胞丢失情况和移植成功率。
将供体对分别储存在Optisol GS溶液和Life4°C溶液中,并准备进行后弹力层剥除自动内皮角膜移植术或后弹力层角膜移植术。将患有Fuchs角膜营养不良的配对受者随机分配到每个供体对的一名成员。随访6个月,观察受者角膜基质的清晰度、眼压和并发症。在筛选时以及内皮角膜移植术后3个月和6个月,由一个盲法中央阅读中心分析供体角膜的中央内皮图像。使用中心法对内皮细胞密度进行双重分级。通过配对分析检查内皮细胞密度和细胞丢失的差异。
共纳入32对,分析了27对(5对匹配不当或失访)。供体年龄为59±14岁,中位死亡至手术时间为4天(范围2 - 9天),6对受者进行了后弹力层角膜移植术,21对进行了后弹力层剥除自动内皮角膜移植术。Optisol GS组和Life4°C组的受者年龄相当(分别为70岁和68岁,P = 0.46)。Life4°C组和Optisol GS组之间6个月时的中央内皮细胞丢失无显著差异(分别为18±18%和20±20%,P = 0.55)。两组中所有受者角膜在6个月时均保持清晰。
对于储存在Optisol GS溶液和Life4°C溶液中的配对供体角膜,6个月时的内皮细胞丢失情况和移植成功率相当。临床试验注册网址:http://www.clinicaltrials.gov。唯一标识符:NCT01657500。